# Intraosseous vs Intravenous Access for Cardiac Arrest Treatment

Study · id `cardio:ct-nct02088736` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02088736](<https://clinicaltrials.gov/study/NCT02088736>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02088736

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1103 participants.

## Technical summary

Registry record NCT02088736. Randomized; single masking; primary purpose treatment. Start 2014-06 (actual); primary completion 2017-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1103 participants (enrolled count; ClinicalTrials.gov record NCT02088736, source copy `cardio:ctgov-nct02088736-2019-10-28`, retrieved 2026-10-26)
- Started: 2014-06 (actual) (ClinicalTrials.gov record NCT02088736, source copy `cardio:ctgov-nct02088736-2019-10-28`, retrieved 2026-10-26)
- Primary completion: 2017-01 (actual) (ClinicalTrials.gov record NCT02088736, source copy `cardio:ctgov-nct02088736-2019-10-28`, retrieved 2026-10-26)
- Completion: 2017-06 (actual) (ClinicalTrials.gov record NCT02088736, source copy `cardio:ctgov-nct02088736-2019-10-28`, retrieved 2026-10-26)
- Countries: Singapore (ClinicalTrials.gov record NCT02088736, source copy `cardio:ctgov-nct02088736-2019-10-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02088736-2019-10-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intraosseous vs Intravenous Access for Cardiac Arrest Treatment
- Condition: Cardiac Arrest
- Intervention (Device): Intraosseous
- Intervention (Device): Intravenous
- Lead sponsor: Singapore General Hospital
- Lead sponsor class: OTHER
- Collaborator: Singapore Civil Defence Force
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: Singapore General Hospital (`cardio:org-singapore-general-hospital`)
- Registry lists this organization as a collaborator: Singapore Civil Defence Force (`cardio:org-singapore-civil-defence-force`)

## Provenance

Content hash: c6bbe12473e65a15cc02bbb2fba589173d2a6e6675386f9dfe8781c52d2404d9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
